Novartis Pharmaceuticals Corporation is dedicated to supporting the needs of those living with Multiple Sclerosis (MS), a chronic disorder of the central nervous system (CNS) that disrupts the normal functioning of the brain, optic nerves and spinal cord through inflammation and tissue loss [1]. In addition to Multiple Sclerosis, we currently offer patients and physicians a large drug portfolio encompassing Alzheimer’s disease, Parkinson’s Disease, Epilepsy, and ADHD. In our research, we leverage advances in human genetics, new imaging technologies and other novel approaches to better understand brain disorders and continue bringing pioneering drugs to patients worldwide. [1] PubMed Health. Multiple Sclerosis (MS). https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024311/. Accessed April 2018. 10/18 XMG-1363777